DIABETES MELLITUS TYPE 2: AN OVERVIEW OF THE CARDIOVASCULAR RISK
Keywords:
Diabetes Mellitus Type 2, risk factor, cardiovascular diseasesAbstract
The prevalence of diabetes mellitus has increased and with it the number of individuals with cardiovascular risk. In order to characterize the approach to cardiovascular risk of type 2 diabetic patients, 56 bibliographies were reviewed. The cardiovascular risk in diabetics is 2-3 times higher than in non-diabetics. It emphasizes the link between insulin resistance and atherosclerotic manifestations and in aspects to consider in the approach to cardiovascular risk type 2 diabetic proposed targets for blood glucose and vascular risk factors are summarized with a view to achieving metabolic control. Concluding that: regardless of estimated cardiovascular risk in patients with type 2 diabetes, the same approach based onthe control of diabetes should be individualized and comprehensive, addressing glycemic control and coexisting vascular risk factors, reducing events atherosclerotic cardiovascular.
References
Fernández J, Bustillo CJ. Diabetes Mellitus. En: Vicente E, Rodríguez AL, Sánchez E, Quintana L, Riverón JM, Ledo D. Diagnóstico y tratamiento en medicina Interna. 2ed, ECIMED. Ciudad Habana; 2012. pp 391- 407.
Shawn JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(1). pp4 -14.
American Diabetes Association. Position Statement. Standards of Medical Care in Diabetes. Diabetes Care. 2012; 35(Suppl 1): S11–S63.
Gran MA, Torres RM, Martínez M, Alonso I, López LM, Velázquez JA, et al. Prevalencia de diabetes mellitus, hipertensión y asma. En Anuario Estadístico de Salud. Edición Especial. La Habana. 2013. p.97.
Organización Mundial de la Salud. Prevención de las enfermedades cardiovasculares. Guía de bolsillo para la estimación y el manejo del riesgo cardiovascular. Ginebra: OMS; 2008[citado 6 Dic 2011]. Disponible en: http://www.who.int/publications/list%20/PocketGL_spanish.pdf.
González A, Gómez R, Casanova M, Hernández L. Riesgo Cardiovascular en enfermos diabéticos. Gaceta Médica Espirituana 2006; 8(1): 1- 4. Disponible en: http://www.bvs.sld.cu/revistas/gme/pub/vol.8.%281%29_06/p6.html
Grau M, Marrugat J. Funciones de riesgo en la prevención primaria de las enfermedades cardiovasculares. Rev Esp Cardiol. 2008; 61(4):404-16. Disponible en: http://www.sciencedirect.com/science/article/pii/S0300893208734092
American Diabetes Association. (2010). Standards of medical care in diabetes—2010. Diabetes care, 33(Supplement 1), S11-S61. Disponible en: http://care.diabetesjournals.org/content/33/Supplement_1/S11.short
García FM, Maderuelo JA, García A. Riesgo Cardiovascular: concepto, estimación, usos y limitaciones. AMF. 2008; 4(8): 123 - 33.
Marrugat J, Subirana I, Comin E , Cabazas C, Vila J, Bosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health.2007; 60(1): 40 – 7. Disponible en: http://jech.bmj.com/content/61/1/40.short
Grundy SM, Bairey Merz CN, Brewer B, Clark LT, Hunninghake DB, Pasternak RC, et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology. 2004; 44.3: 720-732. Disponible en: http://content.onlinejacc.org/article.aspx?articleid=1135860
Grundy SM. Diabetes and Coronary Risk Equivalency: What does it mean? Diabetes Care. 2006; 29(2): 457 - 460. Disponible en: http://care.diabetesjournals.org/content/29/2/457.short
Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009; 26(2):142-8. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1464-5491.2008.02640.x/full
Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had a myocardial infarction: cross sectional and cohort studies. BMJ 2002; 321: 930 - 9. Disponible en: http://www.bmj.com/content/324/7343/939.short
D’Agostino RB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117:743 - 53. Disponible en: http://circ.ahajournals.org/content/117/6/743.short
Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS) Clin Sci (Lond). 2001; 101(6): 671- 9. Disponible en: http://www.clinsci.org/cs/101/cs1010671.htm
Vega J, Guimará M, Vega L. Riesgo cardiovascular, una herramienta útil para la prevención de las enfermedades cardiovasculares. Rev Cubana Med Gen Integr. 2011:27(1)91- 97. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252011000100010&script=sci_arttext&tlng=en
De la Noval R, Armas NB, de la Noval I, Fernández Y, Pupo HB, Dueñas A, et al. Estimación del riesgo cardiovascular global en una población del Área de Salud Mártires de Corynthia. La Habana, Cuba. Rev Cubana Cardiol Cir Cardiovasc. 2011; 17 (1):62 – 68. http://revcardiologia.sld.cu/index.php/revcardiologia/article/viewArticle/20
Dueñas A, Armas NB, Noval RR, Turcios SE, Milán A, Cabalé MB. Riesgo cardiovascular total en los trabajadores del Hotel Meliá Cohiba. Rev Cubana Endocrinol. 2008; 19 (1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000100003&lng=es.
Candelaria JC, Cruz T, Rieumont ER, Acosta C, Alfonso Y. Estimación del riesgo cardiovascular global en pacientes con diabetes mellitus. Medisan 2012; 17(2): 316 – 323. Disponible en: http://new.medigraphic.com/cgi-bin/resumenMain.cgi?IDARTICULO=39927
Aguillo E, Calvo F, Carmena R, Cepero D, Ibarra JM, Navarro J, et al. Diabetes Mellitus y riesgo cardiovascular. Recomendaciones del Grupo de Trabajo Diabetes Mellitus y Enfermedad Cardiovascular de la Sociedad Española de Diabetes, 2009. Av Diabetol. 2009; 25 (6): 449-454. Disponible en: http://dialnet.unirioja.es/servlet/articulo?codigo=3131732
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus. A scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 30(1):162-72. Disponible en: http://care.diabetesjournals.org/content/30/1/162.full.pdf&embedded=true
Madonna R, De Caterina R. Aterogénesis y diabetes: resistencia a la insulina e hiperinsulinemia. Rev Esp Cardiol. 2012; 65(4):309 – 13. Disponible en: http://www.revespcardiol.org/es/content/articulo/90113954/
Molina F, Monedero J, Divisón JA. Complicaciones macrovasculares del paciente diabético. Medicina- Programa de Formación Médica Continuada Acreditado. 2012; 11(17): 1011 –20. Disponible en: http://www.sciencedirect.com/science/article/pii/S0304541212704201
O'Donnel CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del estudio Framingham Heart Study. Rev. Esp. Cardiol. 2008; 61(3): 299 - 310. Disponible en: http://www.sciencedirect.com/science/article/pii/S0300893208733888
Llamazares O, Sastre J, Peña V, Luque A, Cánovas B, Vicente A, et al. Control metabólico y de factores de riesgo cardiovascular en una cohorte de pacientes con diabetes mellitus. Resultados a los 4 años. Endocrinol Nutr. 2012; 59 (2):117-24. Disponible en: http://www.sciencedirect.com/science/article/pii/S1575092211004268
Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, ACCORD Study Group, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364(9):818–828. Disponible en: http://europepmc.org/abstract/med/21366473
Al-Ansary L, Farmer A, Hirst J, Roberts N, Glasou P, Perera R, et al. Point-of-care testing for HbA1C in the management of diabetes: a systematic review and metaanalysis. Clin Chem 2011; 57(4):568 – 576. Disponible en: http://www.clinchem.org/content/57/4/568.short
American Diabetes Asociación. Diabetes care. [Sitio web]. [consultado en diciembre de 2013]. Disponible en: http://care.diabetesjournals.org/?utm_source=Offline&utm_medium=Print&utm_content=diabetescare&utm_campaign=journals&s_src=vanity&s_subsrc=diabetescare
Muñoz I, Martín MB, Agudo MT, García CR, Núñez JM. Riesgo cardiovascular en pacientes diabéticos tipo 2 con o sin síndrome metabólico asociado. Clín Invest Arterioscl. 2011; 23(3):112- 8. Disponible en: http://www.sciencedirect.com/science/article/pii/S0214916811000489
Gaede P, Lund-Andersen H, Parving HH, Perdenson O. Steno – 2 Study: Effect of a multifactorial Intervention on Mortality in Type 2 Diabetes. N Engl J Med 2008; 358(6): 580–91. Disponible en: http://www.nejm.org/doi/full/10.1056/nejmoa0706245
Wang J, Geiss LS, Cheng YJ, Imperatore G, Saydah SH, James C, et al. Long –term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988-2008. Diabetes Care 2011; 34(7):1579–81. Disponible en: http://care.diabetesjournals.org/content/34/7/1579.short
Castelo L, Licea ME. Dislipoproteinemia y diabetes mellitus. Rev Cubana Cardiol Cir Cardiovasc 2010; 16(2):140-55. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/viewArticle/154
Chui M, Austin PC, Manuel DG, Shah BR, Tu JV. Deriving ethnic-specie. BMI cutoff points for assessing diabetes risk. Diabetes Care 2011; 34(8):1741–48. Disponible en: http://care.diabetesjournals.org/content/34/8/1741.short
Fabián MG, Cobo C. Tabaquismo y diabetes. Rev Inst Nal Enf Resp Mex. 2007; 20(2):149–58. Disponible en: http://www.medigraphic.com/pdfs/iner/in-2007/in072i.pdf
Águila Y, Vicente BM, Llaguno GA, Sánchez JF, Costa Cruz M. Efecto del ejercicio físico en el control metabólico y en factores de riesgo de pacientes con diabetes mellitus tipo 2: estudio cuasi experimental. Medwave 2012; 12(10). Disponible en: http://www.mednet.cl/link.cgi/Medwave/Estudios/Investigacion/5547
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal, accept the following terms:
The authors will retain their copyright and guarantee the journal the right of first publication of your work, which will be under a Creative license Commons Attribution-NonCommercial-ShareAlike 4.0 International . (CC BY-NC-SA 4.0).
The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (eg:deposit it in an institutional telemat
